Skip to content
DefDex

Federal award

COMPREHENSIVE DRUG TESTING, INC.

70B06C18F00000395

Contract

Obligated and Ceiling

Obligated (net)
$239,564.75
Ceiling (potential value, not spending)
$257,325.00
Current value
$239,564.75
Gross positive obligations
$257,325.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
COMPREHENSIVE DRUG TESTING, INC. · YM54JZGNDGC5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
COMPREHENSIVE DRUG TESTING, INC. · YM54JZGNDGC5
Awarding agency
Department of Homeland Security · sub-agency 7014 · office 70B06C
Funding agency
Department of Homeland Security · sub-agency 7014
Product or service (PSC)
Q301 · MEDICAL- LABORATORY TESTING
Industry (NAICS)
621111 · OFFICES OF PHYSICIANS (EXCEPT MENTAL HEALTH SPECIALISTS)
PIID
70B06C18F00000395
Parent vehicle (IDV PIID)
HSBP1014D00004
Award type code
C
Actions
6 · May 31, 2018 to Jul 20, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History6

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 20, 2023FY2023P00005C−$630.00
—
Feb 8, 2021FY2021P00004C−$17,130.25
—
Sep 23, 2019FY2019P00003C$40,000.00
—
May 24, 2019FY2019P00002G$87,000.00
—
Jun 28, 2018FY2018P00001M$65,162.50
—
May 31, 2018FY20180—$65,162.50
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.